Elevance Health, Inc. (ELV) Financials
Key financial figures for Elevance Health, Inc. (Q2 2026).
Elevance Health beats again in Q2 2026, raises full-year adjusted EPS guidance to at least $27.00. Adjusted diluted EPS of $7.45 (GAAP diluted EPS $6.71), down from $8.84 in Q2 2025 but ahead of expectations, supported by favorable benefit expense performance and roughly $0.80/share of net below-the-line benefit Benefit expense ratio (MLR) rose to 89.7%, up 80 basis points YoY, driven by elevated medical cost trend in Medicare/Medicaid, partially offset by improved Individual ACA performance; this is the key managed-care margin metric to watch Medical membership fell to 44.9 million, down 469,000 sequentially, on a known commercial fee-based customer transition plus anticipated Individual A. On the outlook: FY2026 adjusted diluted EPS guidance raised to at least $27.00 (from at least $26.75); GAAP diluted EPS guidance raised to at least $20.10; operating cash flow guidance raised to at least $6.0 billion. Figures are for Q2 2026, as Elevance Health, Inc. reported them.
- Revenue
- $50.5B
- Net Income
- $1.5B
- EPS
- $6.71
- Total Assets
- $126.4B
- Operating Cash Flow
- $1.9B
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q2 FY2026 | $50.5B | $1.5B | $6.71 | 4.09% | $1.6B |
| Q1 FY2026 | $50.2B | $1.8B | $8.00 | 5.3% | $4.1B |
| Q4 FY2025 | $49.7B | $547M | $2.47 | 1.17% | -$209M |
| Q3 FY2025 | $50.7B | $1.2B | $5.32 | 3.46% | $775M |
| Q2 FY2025 | $49.8B | $1.7B | $7.72 | 5.29% | $1.8B |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | $199.1B | $5.7B | $25.12 | 4.07% | $3.2B |
| FY2024 | $176.8B | $6.0B | $25.68 | 5.03% | $4.6B |
| FY2023 | $171.3B | $6.0B | $25.22 | 5.1% | $6.8B |
Frequently asked questions
What was Elevance Health, Inc.'s revenue last quarter?
Elevance Health, Inc. reported revenue of $50.47 billion for Q2 FY2026, up 1.4% from the same period a year earlier.
Is Elevance Health, Inc. profitable?
Yes. Elevance Health, Inc. reported net income of $1.46 billion for Q2 FY2026, a net margin of 2.9% on revenue.
How has Elevance Health, Inc.'s margin trended?
Operating margin was 4.09% in Q2 FY2026, compared with 5.29% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
When does Elevance Health, Inc. report next?
Elevance Health, Inc. is scheduled to report results on 2026-10-21. The company has confirmed that date.
Full income statement, balance sheet and cash flow for Elevance Health, Inc. on SentiSense, with up to forty quarters and twenty fiscal years of history.